Status | Study |
Terminated |
Study Name: A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administered in Conjunction With Cisplatin and Etoposide Condition: Carcinoma, Small Cell Date: 2007-09-27 Interventions: Drug: Pomalidomide Other Names |
Terminated |
Study Name: Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma Condition: Carcinoma, Small Cell Lung Date: 2007-02-13 Interventions: Drug: Glufosfamide |
Completed |
Study Name: BI 2536 Second Line Monotherapy in SCLC Condition: Carcinoma, Small Cell Date: 2006-12-18 Interventions: Drug: BI 2536 |
Completed |
Study Name: A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer Condition: Carcinoma, Small Cell Date: 2006-07-27 Interventions: Drug: Sagopilone (BAY86-5302, ZK 219477) |
Terminated |
Study Name: Adjuvant BEmiparin in Small Cell Lung Carcinoma (ABEL STUDY) Condition: Carcinoma, Small Cell Date: 2006-05-09 Interventions: Drug: Bemiparin subcutaneous administration (sc) of Bemiparin (3,500 UI/day) for 26 weeks, starting on t |
Completed |
Study Name: Topotecan and Carboplatin in the First-Line Treatment of Patients With Extensive Stage Small Cell Lung Cancer Condition: Carcinoma, Small Cell Date: 2006-03-20 Interventions: Drug: Topotecan Topotecan 4mg/ |
Completed |
Study Name: Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer Condition: Carcinoma, Small Cell Small Cell Lung Cancer Date: 2006-03-01 Interventions: Drug: SNS-595 Injection |
Completed |
Study Name: Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer Condition: Carcinoma, Small Cell Lung Date: 2006-02-20 Interventions: Drug: irinotecan Drug: carboplatin |
Completed |
Study Name: Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer Condition: Small Cell Lung Cancer Carcinoma, Small Cell Date: 2006-02-16 Interventions: Drug: Topotecan Topotecan 6mg/m2 IV weekly x 6 consecutive weeks followed by a 2 week break. |
Completed |
Study Name: Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer Condition: Carcinoma, Small Cell Lung Cancer Date: 2006-01-27 Interventions: Drug: Vinflunine 320mg/m2 every 21 days as a 15-20 minute infusion |